Achieve recognition of all radiotherapy professions
Hypofractionated, 3-week, preoperative radiotherapy for patients with softæ tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial - Read It Corner
Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE): an international, randomised, phase 3b study - Read It Corner
Retreatment of recurrent or second primary head and neck cancer after prior radiation: executive summary of the American Radium Society® (ARS) appropriate use criteria (AUC): expert panel on radiation oncology - head and neck cancer - Read It Corner
ESTRO ACROP guidelines for external beam radiotherapy of patients with uncomplicated bone metastases - Read It Corner
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): two-year toxicity results from an open-label, randomised, phase III, non-inferiority trial - Read It Corner
ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases - Read It Corner
Corner Editor: Philippe Lambin
Corner Editor: Evert van Limbergen